BACKGROUND
This is the first analysis to estimate the costs of commercially insured patients with Parkinson's disease (PD) in the USA. Prior analyses of PD have not examined costs in patients aged under 65 years, a majority of whom are in the workforce.
OBJECTIVE
Our objective was to estimate direct and indirect costs associated with PD in patients under the age of 65 years who are newly diag...
